HK1042245B - 莫西沙星藥物製劑 - Google Patents

莫西沙星藥物製劑

Info

Publication number: HK1042245B
Authority: HK; Hong Kong
Prior art keywords: pharmaceutical; moxifloxacin preparation; preparation; pharmaceutical moxifloxacin; moxifloxacin
Prior art date: 1998-11-10

Application number

HK02104010.6A

Other languages

English (en)

Other versions

HK1042245A1 (en

Inventor

Bosche Patrick

Friedrich Mahler Hans

Weisemann Claus

Original Assignee

Bayer Ip Gmbh

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1998-11-10

Filing date

2002-05-29

Publication date

2005-03-11

Family has litigation

First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=7889824&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=HK1042245(B) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.

2002-05-29 Application filed by Bayer Ip Gmbh filed Critical Bayer Ip Gmbh

2002-08-09 Publication of HK1042245A1 publication Critical patent/HK1042245A1/xx

2005-03-11 Publication of HK1042245B publication Critical patent/HK1042245B/zh

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/28—Dragees; Coated pills or tablets, e.g. with film or compression coating
- A61K9/2806—Coating materials
- A61K9/2833—Organic macromolecular compounds
- A61K9/286—Polysaccharides, e.g. gums; Cyclodextrin
- A61K9/2866—Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/47—Quinolines; Isoquinolines
- A61K31/4709—Non-condensed quinolines and containing further heterocyclic rings
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
- A61K9/2013—Organic compounds, e.g. phospholipids, fats
- A61K9/2018—Sugars, or sugar alcohols, e.g. lactose, mannitol; Derivatives thereof, e.g. polysorbates
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
- A61K9/2022—Organic macromolecular compounds
- A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
- A61K9/2054—Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents

Landscapes

Health & Medical Sciences (AREA)
Life Sciences & Earth Sciences (AREA)
General Health & Medical Sciences (AREA)
Pharmacology & Pharmacy (AREA)
Medicinal Chemistry (AREA)
Veterinary Medicine (AREA)
Public Health (AREA)
Animal Behavior & Ethology (AREA)
Chemical & Material Sciences (AREA)
Epidemiology (AREA)
Bioinformatics & Cheminformatics (AREA)
Engineering & Computer Science (AREA)
Molecular Biology (AREA)
Biophysics (AREA)
Organic Chemistry (AREA)
Oncology (AREA)
Communicable Diseases (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
General Chemical & Material Sciences (AREA)
Chemical Kinetics & Catalysis (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Medicinal Preparation (AREA)
Saccharide Compounds (AREA)
Nitrogen Condensed Heterocyclic Rings (AREA)
Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)

HK02104010.6A 1998-11-10 2002-05-29 莫西沙星藥物製劑 HK1042245B (zh)

Applications Claiming Priority (2)

Application Number	Priority Date	Filing Date	Title
DE19855758		1998-11-10
PCT/EP1999/008230 WO2000027398A1 (de)	1998-11-10	1999-10-29	Pharmazeutische zubereitung von moxifloxacin

Publications (2)

Publication Number	Publication Date
HK1042245A1 HK1042245A1 (en)	2002-08-09
HK1042245B true HK1042245B (zh)	2005-03-11

Family

ID=7889824

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
HK02104010.6A HK1042245B (zh)	1998-11-10	2002-05-29	莫西沙星藥物製劑

Country Status (41)

Country	Link
US (1)	US6610327B1 (zh)
EP (1)	EP1128831B1 (zh)
JP (1)	JP4809978B2 (zh)
KR (1)	KR100650489B1 (zh)
CN (1)	CN1149993C (zh)
AR (1)	AR021074A1 (zh)
AT (1)	ATE279193T1 (zh)
AU (1)	AU745282B2 (zh)
BG (1)	BG64974B1 (zh)
BR (2)	BR9915208A (zh)
CA (1)	CA2349161C (zh)
CO (1)	CO5070571A1 (zh)
CU (1)	CU23260B7 (zh)
CZ (1)	CZ292069B6 (zh)
DE (1)	DE59910858D1 (zh)
DK (1)	DK1128831T3 (zh)
EE (1)	EE04418B1 (zh)
ES (1)	ES2229786T3 (zh)
HK (1)	HK1042245B (zh)
HN (1)	HN1999000183A (zh)
HR (1)	HRP20010332B1 (zh)
HU (1)	HU229065B1 (zh)
ID (1)	ID29089A (zh)
IL (2)	IL142642A0 (zh)
MA (1)	MA26757A1 (zh)
MY (1)	MY121114A (zh)
NO (1)	NO319342B1 (zh)
NZ (1)	NZ511554A (zh)
PE (1)	PE20001304A1 (zh)
PL (1)	PL194020B1 (zh)
PT (1)	PT1128831E (zh)
RU (1)	RU2230555C9 (zh)
SI (1)	SI1128831T1 (zh)
SK (1)	SK283936B6 (zh)
SV (1)	SV1999000194A (zh)
TR (1)	TR200101310T2 (zh)
TW (1)	TW580388B (zh)
UA (1)	UA72483C2 (zh)
UY (1)	UY25792A1 (zh)
WO (1)	WO2000027398A1 (zh)
ZA (1)	ZA200103141B (zh)

Families Citing this family (31)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
DE19937116A1 (de) *	1999-08-06	2001-02-08	Bayer Ag	Moxifloxacin Kochsalzformulierung
GB0209265D0 (en)	2002-04-23	2002-06-05	Novartis Ag	Organic compounds
WO2005020998A1 (en) *	2003-09-03	2005-03-10	Ranbaxy Laboratories Limited	Pharmaceutical compositions of moxifloxacin and processes for their preparation
CN1330306C (zh) *	2004-08-11	2007-08-08	深圳市天一时科技开发有限公司	莫西沙星明胶胶囊剂及其制备方法
WO2006015545A1 (fr) *	2004-08-11	2006-02-16	Shenzhen Tys R & D Co., Ltd.	Capsule de gelatine de moxifloxacin et procede pour sa preparation
WO2007033522A1 (fr) *	2005-09-21	2007-03-29	Shenzhen Tys R & D Co., Ltd.	Formulation de gélule contenant de la moxifloxacine et son procédé de préparation
WO2007033515A1 (fr) *	2005-09-21	2007-03-29	Shenzhen Tys R & D Co., Ltd.	Formulation orale contenant de la moxifloxacine et son procédé de préparation
CN100363001C (zh) *	2005-09-21	2008-01-23	深圳市天一时科技开发有限公司	一种莫西沙星胶囊剂及其制备方法
MX2011003731A (es) *	2008-10-09	2011-08-03	Abdi Ibrahim Ilac Sanayi Ve Ticaret Anonim Sirketi	Uso de solventes organicos en la granulacion humeda de moxifloxacino.
EP2735307A1 (de)	2008-12-08	2014-05-28	Ratiopharm GmbH	Kompaktiertes Moxifloxacin
TR200907227A2 (tr) *	2009-09-18	2011-04-21	Bi̇lgi̇ç Mahmut	Çözünürlüğü yüksek stabil mikronize granüller.
CN101890169B (zh) *	2009-11-16	2013-09-11	江苏亚邦强生药业有限公司	莫西沙星口服制剂及其制备方法
WO2011086577A2 (en) *	2010-01-12	2011-07-21	Msn Laboratories Limited	Pharmaceutical composition of moxifloxacin and its pharmaceutically acceptable salts
CN102247313A (zh) *	2010-06-11	2011-11-23	北京润德康医药技术有限公司	一种以莫西沙星为活性成分的口服缓释固体制剂
CN102247314A (zh) *	2011-01-12	2011-11-23	北京润德康医药技术有限公司	一种以莫西沙星为活性成分的口服固体制剂
EP2510929A1 (en) *	2011-04-11	2012-10-17	Innocoll Technologies Limited	Methods for treating bacterial infection
MX2011004759A (es)	2011-05-04	2012-11-21	Senosiain S A De C V Lab	Nuevas formas solidas de antibioticos.
RU2466718C1 (ru) *	2011-10-14	2012-11-20	Закрытое акционерное общество "Брынцалов-А"	Фармацевтический препарат моксифлоксацина
CA2853701A1 (en)	2011-10-25	2013-05-02	U.S. Phytotherapy, Inc.	Artemisinin and berberine compositions and methods of making
US9675582B2 (en)	2011-10-25	2017-06-13	U.S. Phytotherapy, Inc.	Alternative ACT with natural botanical active GRAS ingredients for treatment and prevention of the Zika virus
WO2013063271A1 (en) *	2011-10-25	2013-05-02	U.S. Phytotherapy, Inc.	Artemisinin and berberine compositions and methods of making
US9358261B2 (en)	2011-10-25	2016-06-07	U.S. Phytotherapy, Inc.	Additional artemisinin and berberine compositions and methods of making
JP6117112B2 (ja) *	2011-11-30	2017-04-19	富山化学工業株式会社	１−シクロプロピル−８−（ジフルオロメトキシ）−７−［（１ｒ）−１−メチル−２，３−ジヒドロ−１ｈ−イソインドール−５−イル］−４−オキソ−１，４−ジヒドロキノリン−３−カルボン酸のメタンスルホン酸塩水和物含有錠剤
BRPI1106900A2 (pt)	2011-12-26	2013-11-05	Ems Sa	Composição farmacêutica sólida compreendendo antibótico da familia das quinolonas e processo de sua obtenção
CN102525982A (zh) *	2012-02-21	2012-07-04	天津市汉康医药生物技术有限公司	一种稳定的盐酸莫西沙星药物组合物
CN102600093B (zh) *	2012-04-11	2013-06-05	南京优科生物医药有限公司	一种莫西沙星片剂及其制备方法
FR2992218B1 (fr)	2012-06-22	2015-01-23	Rivopharm Sa	Composition pharmaceutique de chlorhydrate de moxifloxacine et procede de preparation
CN103768063B (zh) *	2012-10-19	2016-04-20	深圳信立泰药业股份有限公司	一种盐酸莫西沙星药物组合物及其制备方法
RU2561037C2 (ru) *	2013-02-07	2015-08-20	Открытое акционерное общество "Химико-фармацевтический комбинат "АКРИХИН" (ОАО "АКРИХИН")	Антибактериальная фармацевтическая композиция и способ ее получения
WO2015093669A1 (ko) *	2013-12-20	2015-06-25	씨제이헬스케어 주식회사	목시플록사신 수성 제형 및 이의 제조방법
RU2558932C1 (ru) *	2014-05-22	2015-08-10	Открытое Акционерное Общество "Татхимфармпрепараты"	Фармацевтическая композиция моксифлоксацина и способ ее приготовления

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US5286754A (en)	1986-01-21	1994-02-15	Bayer Aktiengesellschaft	Pharmaceutical formulations of ciprofloxacin
DE3601566A1 (de) *	1986-01-21	1987-07-23	Bayer Ag	Pharmazeutische zubereitungen von ciprofloxacin
JPH01175936A (ja) *	1987-12-28	1989-07-12	Kyorin Pharmaceut Co Ltd	６．８−ジフルオロ−１−（２−フルオロエチル）−１，４−ジヒドロ−７−（４−メチル−１−ピペラジニル）−４−オキソ−３−キノリンカルボン酸を有効成分とする錠剤
DE3906365A1 (de) *	1988-07-15	1990-01-18	Bayer Ag	7-(1-pyrrolidinyl)-3-chinolon- und -naphthyridoncarbonsaeure-derivate, verfahren sowie substituierte (oxa)diazabicyclooctane und -nonane als zwischenprodukte zu ihrer herstellung, und sie enthaltende antibakterielle mittel und futterzusatzstoffe
TW209865B (zh) *	1992-01-10	1993-07-21	Bayer Ag
DE19546249A1 (de) *	1995-12-12	1997-06-19	Bayer Ag	Neue Kristallmodifikation des 1-Cyclopropyl-7-([S,S]-2,8-diazabicyclo[4,3,0]non-8-yl)-6-fluor-1,4-dihydro-8-methoxy-4-oxo-3-chinolincarbonsäure Hydrochlorid (CDCH), Verfahren zu dessen Herstellung und diese enthaltende pharmazeutische Zubereitungen
PA8466701A1 (es) *	1998-01-21	2000-09-29	Pfizer Prod Inc	Comprimido de mesilato de trovafloxacino

1999
- 1999-10-29 AT AT99955906T patent/ATE279193T1/de active
- 1999-10-29 RU RU2001116096/15A patent/RU2230555C9/ru active
- 1999-10-29 ID IDW00200101040A patent/ID29089A/id unknown
- 1999-10-29 AU AU12674/00A patent/AU745282B2/en not_active Expired
- 1999-10-29 KR KR1020017005833A patent/KR100650489B1/ko active IP Right Grant
- 1999-10-29 TR TR2001/01310T patent/TR200101310T2/xx unknown
- 1999-10-29 IL IL14264299A patent/IL142642A0/xx active IP Right Grant
- 1999-10-29 NZ NZ511554A patent/NZ511554A/en not_active IP Right Cessation
- 1999-10-29 DE DE1999510858 patent/DE59910858D1/de not_active Expired - Lifetime
- 1999-10-29 ES ES99955906T patent/ES2229786T3/es not_active Expired - Lifetime
- 1999-10-29 SK SK610-2001A patent/SK283936B6/sk not_active IP Right Cessation
- 1999-10-29 BR BR9915208-8A patent/BR9915208A/pt not_active IP Right Cessation
- 1999-10-29 CA CA002349161A patent/CA2349161C/en not_active Expired - Lifetime
- 1999-10-29 JP JP2000580627A patent/JP4809978B2/ja not_active Expired - Lifetime
- 1999-10-29 US US09/830,770 patent/US6610327B1/en not_active Expired - Lifetime
- 1999-10-29 CZ CZ20011652A patent/CZ292069B6/cs not_active IP Right Cessation
- 1999-10-29 BR BRPI9915208 patent/BRPI9915208B8/pt unknown
- 1999-10-29 EP EP99955906A patent/EP1128831B1/de not_active Expired - Lifetime
- 1999-10-29 UA UA2001063872A patent/UA72483C2/uk unknown
- 1999-10-29 HU HU0104762A patent/HU229065B1/hu unknown
- 1999-10-29 PT PT99955906T patent/PT1128831E/pt unknown
- 1999-10-29 PL PL99348112A patent/PL194020B1/pl unknown
- 1999-10-29 EE EEP200100259A patent/EE04418B1/xx unknown
- 1999-10-29 DK DK99955906T patent/DK1128831T3/da active
- 1999-10-29 WO PCT/EP1999/008230 patent/WO2000027398A1/de active IP Right Grant
- 1999-10-29 CN CNB998131245A patent/CN1149993C/zh not_active Expired - Lifetime
- 1999-10-29 SI SI9930706T patent/SI1128831T1/xx unknown
- 1999-11-01 HN HN1999000183A patent/HN1999000183A/es unknown
- 1999-11-03 AR ARP990105567A patent/AR021074A1/es active IP Right Grant
- 1999-11-04 TW TW088119183A patent/TW580388B/zh not_active IP Right Cessation
- 1999-11-05 MY MYPI99004825A patent/MY121114A/en unknown
- 1999-11-08 UY UY25792A patent/UY25792A1/es not_active Application Discontinuation
- 1999-11-09 PE PE1999001134A patent/PE20001304A1/es not_active IP Right Cessation
- 1999-11-09 CO CO99070667A patent/CO5070571A1/es unknown
- 1999-11-10 SV SV1999000194A patent/SV1999000194A/es active IP Right Grant
2001
- 2001-04-17 IL IL142642A patent/IL142642A/en not_active IP Right Cessation
- 2001-04-18 ZA ZA200103141A patent/ZA200103141B/en unknown
- 2001-04-20 BG BG105459A patent/BG64974B1/bg unknown
- 2001-05-07 NO NO20012248A patent/NO319342B1/no not_active IP Right Cessation
- 2001-05-10 HR HR20010332A patent/HRP20010332B1/xx not_active IP Right Cessation
- 2001-05-10 MA MA26189A patent/MA26757A1/fr unknown
- 2001-05-10 CU CU20010114A patent/CU23260B7/es unknown
2002
- 2002-05-29 HK HK02104010.6A patent/HK1042245B/zh not_active IP Right Cessation

Also Published As

Publication number	Publication date
CZ292069B6 (cs)	2003-07-16
ZA200103141B (en)	2002-05-07
DE59910858D1 (de)	2004-11-18
HRP20010332B1 (en)	2011-01-31
HRP20010332A2 (en)	2002-06-30
HN1999000183A (es)	1999-11-01
KR100650489B1 (ko)	2006-11-28
CZ20011652A3 (cs)	2001-08-15
ATE279193T1 (de)	2004-10-15
KR20010089424A (ko)	2001-10-06
CU23260B7 (es)	2008-01-24
EE04418B1 (et)	2005-02-15
MY121114A (en)	2005-12-30
RU2230555C2 (ru)	2004-06-20
RU2230555C9 (ru)	2006-02-27
HU229065B1 (en)	2013-07-29
CN1149993C (zh)	2004-05-19
AU1267400A (en)	2000-05-29
CO5070571A1 (es)	2001-08-28
ID29089A (id)	2001-07-26
IL142642A (en)	2006-10-05
PE20001304A1 (es)	2000-12-30
WO2000027398A1 (de)	2000-05-18
EP1128831B1 (de)	2004-10-13
NO319342B1 (no)	2005-07-18
JP4809978B2 (ja)	2011-11-09
MA26757A1 (fr)	2004-12-20
SV1999000194A (es)	2000-10-16
BRPI9915208B1 (pt)	2011-11-01
NO20012248L (no)	2001-06-06
AR021074A1 (es)	2002-06-12
HUP0104762A3 (en)	2002-10-28
JP2002529415A (ja)	2002-09-10
IL142642A0 (en)	2002-03-10
BR9915208A (pt)	2001-07-31
BRPI9915208A (pt)	2001-07-31
CA2349161A1 (en)	2000-05-18
EE200100259A (et)	2002-12-16
EP1128831A1 (de)	2001-09-05
TW580388B (en)	2004-03-21
SK283936B6 (sk)	2004-05-04
NO20012248D0 (no)	2001-05-07
BRPI9915208B8 (pt)	2021-07-06
TR200101310T2 (tr)	2001-10-22
AU745282B2 (en)	2002-03-21
UY25792A1 (es)	2001-08-27
NZ511554A (en)	2003-07-25
PL348112A1 (en)	2002-05-06
HK1042245A1 (en)	2002-08-09
DK1128831T3 (da)	2005-01-17
PT1128831E (pt)	2005-01-31
CN1325306A (zh)	2001-12-05
UA72483C2 (en)	2005-03-15
CA2349161C (en)	2008-01-29
US6610327B1 (en)	2003-08-26
HUP0104762A2 (hu)	2002-05-29
ES2229786T3 (es)	2005-04-16
BG64974B1 (bg)	2006-11-30
PL194020B1 (pl)	2007-04-30
SI1128831T1 (en)	2005-04-30
BG105459A (en)	2001-12-29
SK6102001A3 (en)	2001-12-03

Publication	Publication Date	Title
IL142642A0 (en)	2002-03-10	Pharmaceutical moxifloxacin preparation
CZ20011518A3 (cs)	2002-04-17	Farmaceutický prostředek
HK1041224A1 (zh)	2002-07-05	新的藥物製劑
CZ20011186A3 (cs)	2001-09-12	Stabilizovaný farmaceutický prostředek
HUP0203585A3 (en)	2005-01-28	Pharmaceutical combinations
GB9815532D0 (en)	1998-09-16	Pharmaceutical suspension formulation
ZA982073B (en)	1998-09-16	Pharmaceutical preparation
HK1046140A1 (zh)	2002-12-27	固體藥劑
GB9818927D0 (en)	1998-10-21	Pharmaceutical formulation
IL146341A0 (en)	2002-07-25	Pharmaceutical complex
AU1688099A (en)	2000-07-31	Pharmaceutical preparation
GB9909154D0 (en)	1999-06-16	Pharmaceutical formulation
GB9822333D0 (en)	1998-12-09	Pharmaceutical formulation
GB9817470D0 (en)	1998-10-07	Pharmaceutical formulation
GB9926251D0 (en)	2000-01-12	Pharmaceutical formulation
AU2279800A (en)	2000-06-13	Pharmaceutical preparation
GB9802617D0 (en)	1998-04-01	Pharmaceutical formulation
AUPP574298A0 (en)	1998-10-01	Pharmaceutical preparation
HU9902398D0 (en)	1999-10-28	Pharmaceutical preparation
GB9826767D0 (en)	1999-01-27	Pharmaceutical formulation
GB9824502D0 (en)	1999-01-06	Pharmaceutical formulation
GB9817217D0 (en)	1998-10-07	Pharmaceutical formulation
IL120319A0 (en)	1997-06-10	Pharmaceutical preparation
GB9811622D0 (en)	1998-07-29	Drug formulation
GB9926434D0 (en)	2000-01-12	Pharmaceutical

Legal Events

Date	Code	Title	Description
2004-09-30	AS	Change of ownership	Owner name: BAYER HEALTHCARE AG Free format text: FORMER OWNER(S): BAYER AG
2019-11-08	PE	Patent expired	Effective date: 20191028

Date

Code

Title

Description

2004-09-30

Change of ownership

Owner name: BAYER HEALTHCARE AG

Free format text: FORMER OWNER(S): BAYER AG

2019-11-08

Patent expired

Effective date: 20191028